Envestnet Asset Management Inc. Sells 4,135 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Envestnet Asset Management Inc. lessened its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 6.2% in the second quarter, HoldingsChannel reports. The fund owned 62,658 shares of the financial services provider’s stock after selling 4,135 shares during the period. Envestnet Asset Management Inc.’s holdings in iShares Biotechnology ETF were worth $8,600,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Mmbg Investment Advisors CO. increased its position in iShares Biotechnology ETF by 0.6% in the 4th quarter. Mmbg Investment Advisors CO. now owns 78,550 shares of the financial services provider’s stock valued at $10,671,000 after acquiring an additional 495 shares during the period. Oppenheimer & Co. Inc. grew its position in shares of iShares Biotechnology ETF by 7.6% during the 1st quarter. Oppenheimer & Co. Inc. now owns 35,747 shares of the financial services provider’s stock valued at $4,905,000 after acquiring an additional 2,532 shares during the period. Chemistry Wealth Management LLC lifted its stake in shares of iShares Biotechnology ETF by 20.6% during the 1st quarter. Chemistry Wealth Management LLC now owns 3,560 shares of the financial services provider’s stock valued at $488,000 after buying an additional 609 shares in the last quarter. Future Financial Wealth Managment LLC purchased a new stake in shares of iShares Biotechnology ETF in the first quarter worth $27,000. Finally, PFG Advisors raised its position in shares of iShares Biotechnology ETF by 3.9% during the 1st quarter. PFG Advisors now owns 4,655 shares of the financial services provider’s stock valued at $639,000 after buying an additional 173 shares in the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $144.90 on Friday. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $150.57. The business has a 50-day moving average of $145.70 and a 200 day moving average of $138.83.

iShares Biotechnology ETF Announces Dividend

The company also recently disclosed a dividend, which will be paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th will be given a dividend of $0.2005 per share. The ex-dividend date is Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.